Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratympanic Dexamethasone vs Methylprednisolone for Idiopathic Sudden Sensorineural Hearing Loss
TCTR20240930003Phase 3Recruiting
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone, methylprednisolone in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Faculty of Medicine, Chulalongkorn University. Started May 2024; status: recruiting.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on TCTR20240930003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240930003.